Physician profile
Anna Davidov
NPI 1346593183
$9,999.50
in general payments reported to CMS, 2019-2025
19 companies · $3,254 in 2025
The $3,254 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $1,661 · 2023: $2,358 · 2024: $2,189 · 2025: $3,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,800.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,925.88 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $1,040.50 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Renamic Neo |
| Aop Health US, LLC | $749.84 | 2025 | Rapiblyk |
| Abbott Laboratories | $521.10 | 2023-2025 | Assurity, Aveir, Ensite |
| Janssen Pharmaceuticals, INC | $441.55 | 2021-2024 | Xarelto |
| Pfizer INC. | $361.44 | 2021-2025 | |
| Boston Scientific Corporation | $218.72 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse, S-Icd System Magnet |
| Sanofi-Aventis U.S. LLC | $164.34 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $150.41 | 2023-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $100.34 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Kestra Medical Technology Services, INC. | $96.75 | 2022-2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $44.78 | 2025 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $44.44 | 2024 | Arcalyst |
| Philips North America LLC | $38.21 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $24.88 | 2023 | Inpefa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.77 | 2022 | |
| Altathera Pharmaceuticals LLC | $19.40 | 2024 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals, LTD. | $18.15 | 2023 | Arcalyst |
| Baxter Healthcare | $16.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Davidov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.